½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1386121

°í¾çÀÌ¿ë ¹é½Å ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø, °æÀï ºÐ¼®(-2030³â)

Cat Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Lucintel | ÆäÀÌÁö Á¤º¸: ¿µ¹® 150 Pages | ¹è¼Û¾È³» : 3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°í¾çÀÌ¿ë ¹é½Å µ¿Çâ°ú ¿¹Ãø

¼¼°è °í¾çÀÌ¿ë ¹é½Å ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 7.2%ÀÇ CAGR·Î 2030³â±îÁö ¾à 17¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº °í¾çÀÌ »çÀ° ¼öÀÇ Áõ°¡¿Í °í¾çÀÌ Àü¿°º´ ¿¹¹æÀ» À§ÇÑ ¹é½Å Á¢Á¾¿¡ ´ëÇÑ Å« ¼ö¿äÀÔ´Ï´Ù. ¼¼°è °í¾çÀÌ¿ë ¹é½Å ½ÃÀåÀÇ ¹Ì·¡´Â µ¿¹°º´¿ø, Æê¼ó, ¿Â¶óÀÎ ¼Ò¸ÅÁ¡ ä³ÎÀÇ ºñÁö´Ï½º ±âȸ·Î ÀÎÇØ À¯¸ÁÇÑ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

°í¾çÀÌ¿ë ¹é½Å ½ÃÀå ÀλçÀÌÆ®

LucintelÀÇ ¿¹Ãø¿¡ µû¸£¸é, ¾àµ¶¼º »ý¹é½ÅÀº È¿À²¼ºÀÌ ³ô°í Ç×ü ¸é¿ª ¹ÝÀÀ°ú ¼¼Æ÷¼º ¸é¿ª ¹ÝÀÀ ¸ðµÎ¿¡ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ¾ÕÀ¸·Îµµ °¡Àå Å« ºÎ¹®ÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀå Áß µ¿¹°º´¿øÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÏ¹Ì Áö¿ªÀº ½É°¢ÇÑ Áúº´À¸·ÎºÎÅÍ °í¾çÀ̸¦ º¸È£Çϱâ À§ÇÑ ¹é½Å Á¢Á¾¿¡ ´ëÇÑ Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦¿Í ¹Ì±¹ ³» °í¾çÀÌ »çÀ° Áõ°¡·Î ÀÎÇØ °è¼ÓÇؼ­ °¡Àå Å« Áö¿ªÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ±Ô¸ð ¹× ÃßÁ¤Ä¡: °í¾çÀÌ¿ë ¹é½ÅÀÇ ½ÃÀå ±Ô¸ð¸¦ ±Ý¾×(10¾ï ´Þ·¯)À¸·Î ÃßÁ¤.

µ¿Çâ ¹× ¿¹Ãø ºÐ¼®: °¢ ºÎ¹®º°, Áö¿ªº° ½ÃÀå µ¿Çâ(2018-2023³â) ¹× ¿¹Ãø(2024-2030³â)À» ºÐ¼®ÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼®: ±â¼úº°, ¿¬·Éº°, À¯Åë ä³Îº°, Áö¿ªº° °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯).

Áö¿ªº° ºÐ¼®: ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ±âŸ Áö¿ªÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ºÐ¼®.

¼ºÀå ±âȸ: °í¾çÀÌ¿ë ¹é½Å ½ÃÀåÀÇ ±â¼úº°, ¿¬·Éº°, À¯Åë ä³Îº°, Áö¿ªº° ¼ºÀå ±âȸ ºÐ¼®.

Àü·« ºÐ¼®: °í¾çÀÌ¿ë ¹é½Å ½ÃÀåÀÇ M&A, ½ÅÁ¦Ç° °³¹ß, °æÀï »óȲ µî.

Porter's Five Forces ¸ðµ¨À» ±â¹ÝÀ¸·Î ÇÑ »ê¾÷ °æÀï °­µµ ºÐ¼®.

ÀÌ º¸°í¼­´Â ´ÙÀ½°ú °°Àº 11°¡Áö ÁÖ¿ä Áú¹®¿¡ ´ëÇÑ ´äº¯À» ´ã°í ÀÖ½À´Ï´Ù:

  • Q.1. ½ÃÀå ºÎ¹® Áß °¡Àå À¯¸ÁÇÏ°í ¼ºÀ强ÀÌ ³ôÀº ±âȸ´Â ¹«¾ùÀΰ¡?
  • Q.2. ¾î¶² ºÎ¹®ÀÌ ´õ ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ̸ç, ±× ÀÌÀ¯´Â ¹«¾ùÀΰ¡?
  • Q.3. ÇâÈÄ ¼ºÀåÀÌ °¡¼ÓÈ­µÉ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ª°ú ±× ÀÌÀ¯´Â?
  • Q.4. ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡? ½ÃÀåÀÇ ÁÖ¿ä °úÁ¦¿Í ºñÁö´Ï½º ¸®½ºÅ©´Â ¹«¾ùÀΰ¡?
  • Q.5. ÀÌ ½ÃÀå¿¡¼­ÀÇ ºñÁö´Ï½º ¸®½ºÅ©¿Í °æÀï À§ÇùÀº ¹«¾ùÀΰ¡?
  • Q.6. ÀÌ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ±× ÀÌÀ¯´Â?
  • Q.7. ½ÃÀå¿¡¼­ÀÇ °í°´ ¼ö¿ä º¯È­¿¡´Â ¾î¶² °ÍµéÀÌ Àִ°¡?
  • Q.8. ÀÌ ½ÃÀåÀÇ »õ·Î¿î ¹ßÀü°ú ±× ¹ßÀüÀ» ÁÖµµÇÏ°í ÀÖ´Â ±â¾÷Àº?
  • Q.9. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº? ÁÖ¿ä ±â¾÷µéÀº »ç¾÷ ¼ºÀåÀ» À§ÇØ ¾î¶² Àü·«Àû ³ë·ÂÀ» ±â¿ïÀÌ°í Àִ°¡?
  • Q.10. ÀÌ ½ÃÀåÀÇ °æÀï Á¦Ç°¿¡´Â ¾î¶² °ÍµéÀÌ ÀÖÀ¸¸ç, ¼ÒÀç ¹× Á¦Ç° ´ëü¿¡ µû¸¥ ½ÃÀå Á¡À¯À² Ç϶ôÀÇ À§ÇùÀº ¾î´À Á¤µµÀΰ¡?
  • Q.11. Áö³­ 5³â°£ ¾î¶² M&A°¡ ÀÌ·ç¾îÁ³°í, ¾÷°è¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÃƴ°¡?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå : ½ÃÀå ¿ªÇÐ

  • ¼­·Ð, ¹è°æ, ºÐ·ù
  • °ø±Þ¸Á
  • ¾÷°è ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦

Á¦3Àå 2018³âºÎÅÍ 2030³â±îÁö ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • °Å½Ã°æÁ¦ µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå µ¿Çâ(2018-2023³â)°ú ¿¹Ãø(2024-2030³â)
  • ±â¼úº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
    • ¾àµ¶È­ »ý¹é½Å
    • °áÇÕ ¹é½Å
    • ºÒÈ°È­ ¹é½Å
    • ¾Æ´ÜÀ§ ¹é½Å
    • Åå¼ÒÀÌµå ¹é½Å
    • DNA ¹é½Å
    • ÀçÁ¶ÇÕ ¹é½Å
  • ¿¬·Éº° ¼¼°è °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
    • 6°³¿ù ¹Ì¸¸
    • 6°³¿ù ÀÌ»ó
  • À¯Åë ä³Îº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
    • µ¿¹° º´¿ø
    • ¹Ý·Áµ¿¹° ¼ó
    • ¿Â¶óÀÎ ¼Ò¸Å¾÷ü

Á¦4Àå 2018³âºÎÅÍ 2030³â±îÁö Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®

  • Áö¿ªº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
  • ºÏ¹ÌÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
  • À¯·´ÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå
  • ±âŸ Áö¿ªÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå

Á¦5Àå °æÀï ºÐ¼®

  • Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
  • ¿î¿µ»ó ÅëÇÕ
  • Porter's Five Forces ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

  • ¼ºÀå ±âȸ ºÐ¼®
    • ±â¼úº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ¼ºÀå ±âȸ
    • ¿¬·Éº° ¼¼°è °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ¼ºÀå ±âȸ
    • À¯Åë ä³Îº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ¼ºÀå ±âȸ
    • Áö¿ªº° ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ¼ºÀå ±âȸ
  • ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀåÀÇ »õ·Î¿î µ¿Çâ
  • Àü·«Àû ºÐ¼®
    • ½ÅÁ¦Ç°ÀÇ °³¹ß
    • ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå »ý»ê´É·Â È®´ë
    • ¼¼°èÀÇ °í¾çÀÌ¿ë ¹é½Å ½ÃÀå ÇÕº´, Àμö, ÇÕÀÛÅõÀÚ
    • ÀÎÁõ°ú ¶óÀ̼±½Ì

Á¦7Àå À¯·Â ±â¾÷ÀÇ ±â¾÷ °³¿ä

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta
ksm 23.12.07

Cat Vaccine Trends and Forecast

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

A more than 150-page report is developed to help in your business decisions.

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Cat Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

  • Below 6 Months
  • Above 6 Months

Cat Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Clinics
  • Pet Stores
  • Online Retailers

Cat Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Cat Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Within this market, veterinary clinics is expected to witness highest growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cat vaccine market size?

Answer: The global cat vaccine market is expected to reach an estimated $1.7 billion by 2030.

Q.2 What is the growth forecast for cat vaccine market?

Answer: The global cat vaccine market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cat vaccine market?

Answer: The major drivers for this market are rising cat ownership and significant demand for vaccinations to prevent cat-transmitted diseases.

Q4. What are the major segments for cat vaccine market?

Answer: The future of the cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels.

Q5. Who are the key cat vaccine market companies?

Answer: Some of the key cat vaccine companies are as follows:

  • Elanco Animal Health
  • Boehringer Ingelheim
  • Merck
  • Zoetis
  • Bioveta

Q6. Which cat vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to its high efficiency and helps for both antibody and cellular immune responses.

Q7. In cat vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the cats from serious diseases and rising adoption of cats in the USA.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cat Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cat Vaccine Market by Technology
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Inactivated Vaccines
    • 3.3.4: Subunit Vaccines
    • 3.3.5: Toxoid Vaccines
    • 3.3.6: DNA Vaccines
    • 3.3.7: Recombinant Vaccines
  • 3.4: Global Cat Vaccine Market by Age
    • 3.4.1: Below 6 Months
    • 3.4.2: Above 6 Months
  • 3.5: Global Cat Vaccine Market by Distribution Channel
    • 3.5.1: Veterinary Clinics
    • 3.5.2: Pet Stores
    • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cat Vaccine Market by Region
  • 4.2: North American Cat Vaccine Market
    • 4.2.2: North American Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.3: European Cat Vaccine Market
    • 4.3.1: European Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.3.2: European Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.4: APAC Cat Vaccine Market
    • 4.4.1: APAC Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.4.2: APAC Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
  • 4.5: ROW Cat Vaccine Market
    • 4.5.1: ROW Cat Vaccine Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
    • 4.5.2: ROW Cat Vaccine Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
    • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
    • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cat Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Elanco Animal Health
  • 7.2: Boehringer Ingelheim
  • 7.3: Merck
  • 7.4: Zoetis
  • 7.5: Bioveta
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦